466 related articles for article (PubMed ID: 16054263)
1. Pulmonary DNA vaccination: concepts, possibilities and perspectives.
Bivas-Benita M; Ottenhoff TH; Junginger HE; Borchard G
J Control Release; 2005 Sep; 107(1):1-29. PubMed ID: 16054263
[TBL] [Abstract][Full Text] [Related]
2. Intranasal formulations: promising strategy to deliver vaccines.
Riese P; Sakthivel P; Trittel S; Guzmán CA
Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization: a review of strategies and challenges.
Patel H; Yewale C; Rathi MN; Misra A
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
[TBL] [Abstract][Full Text] [Related]
4. ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.
Timothy AA; Tokanovic A; Snibson KJ; Edwards SJ; Pearse MJ; Scheerlinck JP; Sutton P
Hum Vaccin Immunother; 2015; 11(2):377-85. PubMed ID: 25692970
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
[TBL] [Abstract][Full Text] [Related]
6. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
7. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
8. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics.
Lee JS; Yoon S; Han SJ; Kim ED; Kim J; Shin HS; Seo KY
Expert Rev Vaccines; 2022 Jan; 21(1):91-101. PubMed ID: 34788181
[TBL] [Abstract][Full Text] [Related]
9. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
10. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
11. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland genetic vaccination: a scalable technology for promoting distal mucosal immunity and heightened systemic immune responses.
Tucker SN; Lin K; Stevens S; Scollay R; Bennett MJ; Olson DC
Vaccine; 2004 Jun; 22(19):2500-4. PubMed ID: 15193415
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of local antibody production: parenteral or mucosal vaccination?
Bouvet JP; Decroix N; Pamonsinlapatham P
Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
[TBL] [Abstract][Full Text] [Related]
14. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
Horvath CN; Xing Z
Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
[TBL] [Abstract][Full Text] [Related]
15. Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.
Caetano LA; Almeida AJ; Gonćalves LM
J Biomed Nanotechnol; 2014 Sep; 10(9):2295-316. PubMed ID: 25992458
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa.
Tang J; Cai L; Xu C; Sun S; Liu Y; Rosenecker J; Guan S
Nanomaterials (Basel); 2022 Jan; 12(2):. PubMed ID: 35055244
[TBL] [Abstract][Full Text] [Related]
17. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
18. Sublingual vaccination and delivery systems.
Paris AL; Colomb E; Verrier B; Anjuère F; Monge C
J Control Release; 2021 Apr; 332():553-562. PubMed ID: 33737202
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategies for mucosal immune responses.
Ogra PL; Faden H; Welliver RC
Clin Microbiol Rev; 2001 Apr; 14(2):430-45. PubMed ID: 11292646
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments.
Shoji M; Katayama K; Tachibana M; Tomita K; Sakurai F; Kawabata K; Mizuguchi H
Vaccine; 2012 Nov; 30(50):7278-85. PubMed ID: 23036499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
